ABAmy Brodtmann

Amy Brodtmann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Amy Brodtmann has a total of 49 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Phenocopy or variant: a longitudinal study of very slowly progressive frontotemporal dementia

    by Amy Brodtmann, Tiffany Cowie, Catriona McLean, David Darby

    Frontal variant frontotemporal dementia (fvFTD) can present with a range of social and cognitive impairments. Complicating this clinical picture is a group of non-progressive or ‘phenocopy’ patients. We present a patient and his father with very slowly progressive fvFTD over decades. Stable MRI and positron emission tomography (PET) imaging abnormalities were present in the presenting patient, with serial neuropsychological assessments that showed no significant change over 15 years. His father also had a 20-year history of functional decline, associated with neuropsychological evidence of change. Neuropathological confirmation of the condition of his father became available. This revealed gross bilateral frontal atrophy and spongiosis in the frontal cortical regions with mild neuronal loss and rounded ubiquitinated perinuclear inclusions, consistent with early stage frontotemporal lobar degeneration with ubiquitin by current neuropathological criteria. The phenotype of frontal variant FTD is broad. Many patients present with frontal networks dysfunction. We present evidence that some patients with a very slow clinical progression do have FTD.


  • Hashimoto Encephalopathy and Down Syndrome

    by Amy Brodtmann

    Background Hashimoto encephalopathy is a potentially fatal condition associated with a presentation of myoclonus, altered conscious state, strokelike episodes, rapid cognitive decline, and neuropsychiatric symptoms. Both congenital hypothyroidism and acquired hypothyroidism are common in patients with Down syndrome. Objective To describe the presentation of Hashimoto encephalopathy in patients with Down syndrome. Design Clinical case reports. Setting General neurology unit. Patients Two Down syndrome patients diagnosed as having Hashimoto encephalopathy are described. Intervention High-dose oral corticosteroids. Main Outcome Measures Neurologic examination, electroencephalography, and blood analysis results. Results Both patients responded to treatment, with a slow return to their premorbid level of function. Conclusion Hashimoto encephalopathy should be considered in Down syndrome patients with rapidly progressive cognitive decline.


  • Regional fMRI brain activation does correlate with global brain volume

    by Amy Brodtmann, Aina Puce, David Darby, Geoffrey Donnan


  • Serial Functional Imaging Poststroke Reveals Visual Cortex Reorganization

    by Amy Brodtmann, Aina Puce, David Darby, Geoffrey Donnan

    Purpose. Visual cortical reorganization following injury remains poorly understood. The authors performed serial functional magnetic resonance imaging (fMRI) on patients with visual cortex infarction to evaluate early and late striate, ventral, and dorsal extrastriate cortical activation. Methods. Patients were studied with fMRI within 10 days and at 6 months. The authors used a high-level visual activation task designed to activate the ventral extrastriate cortex. These data were compared to those of age-appropriate healthy control participants. Results. The results from 24 healthy control individuals (mean age 65.7 ± SE 3.6 years, range 32-89) were compared to those from 5 stroke patients (mean age 73.8 ± SE 7 years, range 49-86). Patients had infarcts involving the striate and ventral extrastriate cortex. Patient activation patterns were markedly different to controls. Bilateral striate and ventral extrastriate activation was reduced at both sessions, but dorsal extrastriate activated voxel counts remained comparable to controls. Conversely, mean percent magnetic resonance signal change increased in dorsal sites. Conclusions. These data provide strong evidence of bilateral poststroke functional depression of striate and ventral extrastriate cortices. Possible utilization or surrogacy of the dorsal visual system was demonstrated following stroke. This activity could provide a target for novel visual rehabilitation therapies.


  • fMRI Demonstrates Diaschisis in the Extrastriate Visual Cortex

    by Amy Brodtmann, Aina Puce, David Darby, Geoffrey Donnan

    Background and Purpose— Diaschisis may play a critical role in motor recovery, but in other cortical networks its role is unclear. Some visual system regions, such as the fusiform gyri, depend on intact striate regulation for their function. We evaluated visual cortical diaschisis by serial functional magnetic resonance imaging. Methods— Using a high-level visual activation task, we studied patients with visual system stroke by functional magnetic resonance imaging within 10 days and at 6 months. Their activation data were compared with those of age-appropriate healthy control subjects. Results— Three patients were studied. In the short term, patients displayed absent or significantly reduced activation in ventral extrastriate sites. All displayed a restitution of activation to these sites at 6 months. Conclusions— Functional magnetic resonance imaging revealed evidence of ipsilesional cortical diaschisis within ventral extrastriate sites. Diaschisis may play an underrecognized role in visual recovery after stroke.


  • The functional magnetic resonance imaging hemodynamic response to faces remains stable until the ninth decade

    by Amy Brodtmann, Aina Puce, Ari Syngeniotis, David Darby, Geoffrey Donnan


  • Functional MRI and stroke

    by Amy Brodtmann, Leeanne Carey, David G. Darby

    The role of functional magnetic resonance imaging (FMRI) in patients with stroke is still in evolution. This chapter describes the history of FMRI development, and outlines recent contributions to the understanding of stroke-related brain dysfunction and ends with recommendations for future research in stroke using FMRI. The first report of the mapping of functional changes in regional human brain function using FMRI was done by Belliveau and his group. Imaging sequences are only one important aspect of FMRI. The majority of FMRI work to date has focused on academic studies clarifying brain-behaviour relationships. FMRI studies have significant advantages allowing non-invasive radioisotope-free serial studies of recovering association cortex. Little FMRI work has been done to date to examine recovery following damage to other brain areas or functions. Future integrative research correlating perfusion-diffusion characteristics and site of FMRI activation might shed light on factors predictive of recovery.

  • Magnetic Resonance Imaging in Stroke

    by Marc Fisher, Steven Warach, John N. Fink, Louis R. Caplan, P. Alan Barber, Stephen M. Davis, Rüdiger von Kummer, Lawrence R. Wechsler, Steven Goldstein, Howard Yonas, et al.

    Magnetic resonance imaging provides non-invasive information about the brain's blood flow, water movement and biochemical abnormalities following stroke, and advances in magnetic resonance imaging (MRI) are transforming the investigation and treatment of cerebrovascular disease. Echoplanar techniques with diffusion and perfusion weighted imaging, together with developments in magnetic resonance spectroscopy and angiography, are replacing CT scanning as the diagnostic modality of choice. In this profusely illustrated book world leaders in these technologies review the scientific basis and clinical applications of MRI in stroke. It will appeal to a broad readership including stroke physicians, neurologists, neurosurgeons, rehabilitation specialists, and others with a clinical or research interest in cerebrovascular disease.